|
- Alkermes – A Global Biopharmaceutical Company
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience
- Alkermes plc - Wikipedia
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders The company was founded in 1987 by Michael Wall [3]
- Even through its remake, Alkermes retains its upward trajectory
Alkermes is showcasing its rare set of attributes as a pure-play neuroscience biotech that is self-funded and has an intriguing pipeline program
- Pharmaceutical Biotechnology Careers Jobs | Alkermes
Alkermes offers pharmaceutical and biotechnology careers in the United States and Dublin, Ireland See our list of biopharmaceutical jobs for current openings
- About Alkermes | Alkermes
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders
- Proprietary Third-Party Medicines | Alkermes
Alkermes has medicines for addiction, schizophrenia and bipolar I disorder, and treatments in development for neurological disorders and sleep disorders such as narcolepsy and idiopathic hypersomnia
- Pipeline | Alkermes
We have a pipeline of product candidates in development for psychiatric and neurological disorders These programs are investigating treatments or indications that have not received approval from a health authority The information presented is not intended to convey conclusions of safety or efficacy There is no guarantee that the outcome of these studies will result in approval by a health
- Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 . . .
Alkermes plans to present detailed safety and efficacy results from the Vibrance-1 phase 2 study in an oral presentation at the upcoming World Sleep Congress, taking place Sept 5-10, 2025 in Singapore
|
|
|